v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenues:    
Product revenue, net $ 311,337 $ 137,250
Revenue from Contract with Customer, Product and Service [Extensible Enumeration] Product [Member] Product [Member]
Operating expenses:    
Cost of sales $ 26,847 $ 4,513
Research and development 108,692 44,172
Selling, general and administrative 268,521 167,876
Total operating expenses 404,060 216,561
Loss from operations (92,723) (79,311)
Interest income 8,243 9,370
Interest expense (7,819) (3,297)
Other expense, net (2,092) 0
Net loss $ (94,391) $ (73,238)
Net loss per common, Series A preferred and Series B preferred share:    
Basic net loss per common, Series A preferred, and Series B preferred share (in dollars per share) $ (3.25) $ (2.61)
Diluted net loss per common, Series A preferred, and Series B preferred share (in dollars per share) $ (3.25) $ (2.61)
Basic weighted average number of shares outstanding (Note 13) (in shares) 29,032,422 28,085,234
Diluted weighted average number of shares outstanding (Note 13) (in shares) 29,032,422 28,085,234